AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing
The Treasury has reassured that it remains in “positive discussions” with AstraZeneca regarding the pharmaceutical giant’s proposed £450 million vaccine…
NICE’s methodology means people with cancer aren’t getting drugs – AstraZeneca’s Sir Pascal Soriot said
The chief executive of AstraZeneca has criticised a public health body for refusing to make one of its breast cancer…
